Captrust Financial Advisors Plus Therapeutics, Inc. Transaction History

Captrust Financial Advisors

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 23, 2022	SELL	$0.46 - $1.02 $0 - $1	-1 Reduced 5.88%	16 $0
Q2 2022 Aug 16, 2022	BUY	$0.46 - $1.02 $0 - $1	1 Added 6.25%	17 $0
Q1 2022 May 16, 2022	SELL	$0.87 - $1.32 $0 - $1	-1 Reduced 5.88%	16 $0
Q4 2021 Feb 14, 2022	BUY	$1.03 - $1.94 $17 - $32	17 New	17 $0
Q1 2021 May 17, 2021	SELL	$2.1 - $3.75 $37 - $67	-18 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$1.43 - $2.33 $25 - $41	18 New	18 $0
Q4 2019 Feb 14, 2020	SELL	$1.99 - $3.23 $35 - $58	-18 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$3.3 - $19.25 $59 - $346	18 New	18 $0

Ticker PSTV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,601,400
Market Cap $40M
Description
Plus Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the development, manufacture, and commercialization of treatments for patients with cancer and other diseases. Its lead drug candidate is Rhenium-186 NanoLiposome, a patented radiotherapy that targets central nervous system cancers, including recurrent glioblastoma, lep...

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

Stay updated on Captrust Financial Advisors with notifications on news.